TrialNature medicine2025

Targeting the angiopoietin-like protein 3/8 complex with a monoclonal antibody in patients with mixed hyperlipidemia: a phase 1 trial.

Daniel Gaudet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.